Business Context and Reporting Period
This Form 8-K Current Report was filed by Phio Pharmaceuticals Corp. on January 13, 2020, regarding events occurring on January 10, 2020, and January 13, 2020. The filing details a corporate action approved by stockholders to implement a reverse stock split of the Company's common stock.
Key Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial figure disclosed is the valuation used for fractional share cash payments.
- Fractional Share Payment Rate: $10.62 per share (average of closing prices during the ten consecutive trading days ending January 13, 2020).
Material Changes
The primary material change is the implementation of a 1-for-55 reverse stock split of the Company's common stock.
- Share Count Reduction: Issued and outstanding shares will decrease from approximately 36.8 million to approximately 0.67 million.
- Effective Date: The split becomes effective at 12:01 a.m. (Eastern Time) on January 15, 2020.
- Trading Symbol: The symbol "PHIO" remains unchanged on The Nasdaq Capital Market.
- Authorized Shares: The number of authorized shares was not reduced, increasing the number of shares available for future issuance relative to outstanding shares.
- Equity Awards: Exercise prices and share counts for outstanding equity awards and warrants will be proportionately adjusted.
Guidance, Outlook, and Unusual Items
The filing does not provide forward-looking guidance, management commentary on financial performance, or risk factors beyond the mechanics of the stock split. The unusual item is the specific treatment of fractional shares:
- No fractional shares will be issued.
- Stockholders entitled to fractional shares will receive a cash payment calculated by multiplying the fraction by $10.62.
- Post-split shares will be issued via Computershare's Direct Registration System (book-entry) unless paper certificates are requested.
Investor Verification Checklist
- Verify the new CUSIP number for the common stock: 71880W303.
- Confirm the effective trading date of the post-split shares: January 15, 2020.
- Check instructions from brokers or Computershare regarding the exchange of pre-split shares and receipt of cash for fractional shares.
- Review the adjustment to the number of shares and exercise prices for any held equity awards or warrants.